SCHEMBL979981

SCHEMBL979981

N#CCCOC(=O)OCCC#N

nearest known ligand 0.40

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
MCL1 Q07820 1/20 0.32
GAA P10253 1/20 0.31
LOX P28300 1/20 0.30
LOXL3 P58215 1/20 0.30
LOXL2 Q9Y4K0 1/20 0.30
CYP3A4 P08684 1/20 0.30
TSHR P16473 1/20 0.30
SLC1A2 P43004 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL9998504 0.97 MEN1 (0.38) MEN1KMT2AALDH1A1TDP1MCL1
SCHEMBL6364761 0.89 ALDH1A1 (0.56) MEN1KMT2AALDH1A1GAATSHR
SCHEMBL22558205 0.89 MEN1 (0.41) MEN1KMT2AALDH1A1TDP1MCL1
SCHEMBL17935659 0.87 MEN1 (0.36) MEN1KMT2A
SCHEMBL28668643 0.85
SCHEMBL22557935 0.85 ALDH1A1 (0.48) MEN1KMT2AALDH1A1TDP1TSHR
SCHEMBL22557949 0.84 MEN1 (0.36) MEN1KMT2AALDH1A1TDP1CYP3A4
SCHEMBL25237284 0.83 MEN1 (0.39) MEN1KMT2AALDH1A1TDP1MCL1
SCHEMBL22558132 0.83 NAAA (0.47) ALDH1A1CYP3A4TSHR
SCHEMBL31734554 0.83 HTT (0.41) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024191025-A1 COSMETIC COMPOSITION COMPRISING CAPSULES OR BEADS 한국콜마주식회사 2024-09-19 WO claimed
WO-2016151508-A1 METHOD AND APPARATUS FOR THE PRODUCTION OF DIARYL CARBONATE SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2016-09-29 WO claimed
CN-111148744-B Novel heterocyclic compounds as MGLUR7 modulators 布拉格玛治疗公司 2025-02-14 CN disclosed
US-20250051259-A1 METHOD FOR PRODUCING HIGHLY PURE DIARYL CARBONATE ASAHI KASEI KABUSHIKI KAISHA (JP) 2025-02-13 US disclosed
US-20240400496-A1 METHOD FOR PRODUCING DIPHENYL CARBONATE ASAHI KASEI KABUSHIKI KAISHA (JP) 2024-12-05 US disclosed
WO-2024191025-A1 COSMETIC COMPOSITION COMPRISING CAPSULES OR BEADS 한국콜마주식회사 2024-09-19 WO disclosed
EP-4421063-A1 METHOD FOR PRODUCING DIPHENYL CARBONATE Asahi Kasei Kabushiki Kaisha (JP) 2024-08-28 EP disclosed
EP-4414357-A1 METHOD FOR PRODUCING HIGH-PURITY DIARYL CARBONATE Asahi Kasei Kabushiki Kaisha (JP) 2024-08-14 EP disclosed
WO-2023068288-A1 METHOD FOR PRODUCING DIPHENYL CARBONATE 旭化成株式会社 2023-04-27 WO disclosed
WO-2023058681-A1 METHOD FOR PRODUCING HIGH-PURITY DIARYL CARBONATE 旭化成株式会社 2023-04-13 WO disclosed
CN-108586254-B Process for producing diaryl carbonate and process for producing aromatic polycarbonate 旭化成株式会社 2021-06-18 CN disclosed
EP-0781760-A1 Continuous manufacturing method for aromatic carbonates GENERAL ELECTRIC COMPANY (US) 1997-07-02 EP disclosed
EP-0780361-A1 Manufacturing method for aromatic carbonates GENERAL ELECTRIC COMPANY (US) 1997-06-25 EP disclosed
EP-0779312-A2 Manufacturing method for polycarbonate GENERAL ELECTRIC COMPANY (US) 1997-06-18 EP disclosed
CN-1121076-A 1,4-diazepine derivative and its pharmaceutical use EISAI CO LTD (JP) 1996-04-24 CN disclosed
CN-1028640-C 1, 4-diazepine derivatives and their use as herbicides EISAI CO LTD (JP) 1995-05-31 CN disclosed
EP-0461274-B1 PROCESS FOR CONTINUOUSLY PRODUCING AROMATIC CARBONATE ASAHI CHEMICAL IND (JP) 1994-06-15 EP disclosed
US-5210268-A Ester interchange, catalysis ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1993-05-11 US disclosed
EP-0461274-A1 PROCESS FOR CONTINUOUSLY PRODUCING AROMATIC CARBONATE Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1991-12-18 EP disclosed
CN-1042356-A 1, 4-diaza * derivatives and their pharmaceutical use EISAI CO LTD (JP) 1990-05-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250051259-A1 METHOD FOR PRODUCING HIGHLY PURE DIARYL CARBONATE CA9, CA3, CEL MEN1 1735/4885KMT2A 936/4885ALDH1A1 2773/4885
US-20240400496-A1 METHOD FOR PRODUCING DIPHENYL CARBONATE HBB, HBG2, HBG1 MEN1 3578/4885KMT2A 1524/4885ALDH1A1 1738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.